January 24, 2018

Prokaryotics an ILSE Startup Announces Licensing Agreement with Merck

Prokaryotics Announces Licensing Agreement with Merck for Novel Investigational Antibiotic Candidates   Union, NJ – January 25, 2018 — Prokaryotics, Inc., a privately-held biopharmaceutical company engaged […]